Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$31.15 - $33.39 $3.22 Million - $3.46 Million
103,510 Added 8.56%
1,312,383 $43.6 Million
Q3 2022

Nov 15, 2022

BUY
$30.9 - $33.55 $32.3 Million - $35.1 Million
1,045,516 Added 640.02%
1,208,873 $38.1 Million
Q2 2022

Aug 15, 2022

BUY
$23.75 - $31.69 $565,843 - $755,014
23,825 Added 17.07%
163,357 $4.97 Million
Q1 2022

May 13, 2022

BUY
$19.97 - $26.94 $3,774 - $5,091
189 Added 0.14%
139,532 $3.62 Million
Q4 2021

Feb 14, 2022

BUY
$17.46 - $21.61 $1,257 - $1,555
72 Added 0.05%
139,343 $2.84 Million
Q3 2021

Nov 10, 2021

SELL
$17.35 - $22.5 $133,421 - $173,025
-7,690 Reduced 5.23%
139,271 $2.68 Million
Q2 2021

Jul 30, 2021

SELL
$18.01 - $28.32 $438,489 - $689,507
-24,347 Reduced 14.21%
146,961 $3.26 Million
Q1 2021

May 06, 2021

BUY
$19.76 - $29.89 $1.24 Million - $1.88 Million
62,897 Added 58.02%
171,308 $4.5 Million
Q4 2020

Feb 08, 2021

SELL
$15.73 - $21.66 $218,961 - $301,507
-13,920 Reduced 11.38%
108,411 $2.03 Million
Q3 2020

Nov 12, 2020

BUY
$13.54 - $26.41 $547,747 - $1.07 Million
40,454 Added 49.41%
122,331 $2.08 Million
Q2 2020

Aug 13, 2020

SELL
$7.84 - $23.29 $8,310 - $24,687
-1,060 Reduced 1.28%
81,877 $1.91 Million
Q1 2020

May 14, 2020

BUY
$5.57 - $11.5 $278 - $575
50 Added 0.06%
82,937 $697,000
Q4 2019

Feb 18, 2020

BUY
$7.9 - $10.14 $2,765 - $3,549
350 Added 0.42%
82,887 $810,000
Q3 2019

Nov 14, 2019

SELL
$9.17 - $12.01 $88,949 - $116,497
-9,700 Reduced 10.52%
82,537 $783,000
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $188,224 - $304,480
17,300 Added 23.09%
92,237 $1.1 Million
Q4 2018

Feb 13, 2019

SELL
$14.52 - $19.72 $27,588 - $37,468
-1,900 Reduced 2.47%
74,937 $1.3 Million
Q2 2018

Aug 13, 2018

SELL
$13.8 - $16.8 $34,500 - $42,000
-2,500 Reduced 3.15%
76,837 $1.22 Million
Q3 2017

Nov 13, 2017

BUY
$13.45 - $14.35 $1.07 Million - $1.14 Million
79,337
79,337 $1.14 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.